Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.

Saved in:
Bibliographic Details
Title: Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.
Authors: Bryant JM; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA., Sandoval M; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Putney R; Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Trivedi P; Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Katende EN; Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Fink A; Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Naqvi SM; Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kim Y; Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Yin V; Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Zhang J; Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Park JY; Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Serna A; Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Lam N; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Pow-Sang J; Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Poch M; Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Li R; Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Manley BJ; Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Naghavi A; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Torres-Roca J; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Grass GD; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kim S; Radiation Oncology, Mayo Clinic Alix College of Medicine & Health Sciences, Jacksonville, Florida, USA., Latifi K; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Hunt D; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Johnstone P; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Dhillon J; Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Rodriguez PC; Immuno-Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Jain R; Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York, USA., Fernandez DC; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Yamoah K; Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA kosj.yamoah@moffitt.org.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 May 04; Vol. 14 (5). Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-013906